➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Colorcon
Merck
Mallinckrodt
Baxter

Last Updated: October 16, 2021

DrugPatentWatch Database Preview

Details for Biologics License Application: 125338


Email this page to a colleague

« Back to Dashboard

Summary for BLA: 125338
Tradename:XIAFLEX
Applicant:Auxilium Pharms
Ingredient:collagenase clostridium histolyticum
Patents:11
Approval Date:Feb 02, 2010
Suppliers: see list1

US Patents for BLA: 125338

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial BioSpecifics Technologies Corporation (Lynbrook, NY) Duke University (Durham, NC) 2033-03-15 RX Orphan search
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial RX Orphan search
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial Advance Biofactures of Curacao (Curacao, AN) 2039-03-29 RX Orphan company
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial Ethicon, Incorporated (Somerville, NJ) 2023-06-27 RX Orphan search
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial Auxilium US Holdings, LLC (Wilmington, DE) 2026-01-30 RX Orphan company
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial Asan Laboratories Company (Cayman) Limited (Taipei, TW) 2022-04-26 RX Orphan search
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 2010-02-02 ⤷  Free Forever Trial Asan Laboratories Company (Cayman), Limited (Taipei, TW) 2022-04-26 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Johnson and Johnson
McKinsey
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.